Anna M. Czarnecka

Cited by

	All	Since 2019
Citations	5217	3426
h-index	38	31
i10-index	122	89

820

410

205

615

200620072008200920102011201220132014201520162017201820192020202120222023202414 28 60 83 118 88 89 113 139 175 227 271 354 394 481 662 818 797 262

Public access

View all

15 articles

1 article

available

not available

Based on funding mandates

Co-authors

Ewa BartnikProfessor of Genetics, University of WarsawVerified email at igib.uw.edu.pl
wojtek KukwaMedical University of WarsawVerified email at wum.edu.pl
Michał FiedorowiczMossakowski Medical Research Centre, PASVerified email at imdik.pan.pl
Bożena Cybulska-StopaNarodowy Instytut Onkologii (NIO)Verified email at vp.pl
Francesco CappelloProfessore Ordinario di Istologia, Università degli Studi di Palermo, Palermo, ItalyVerified email at unipa.it
Zofia Felicja BieleckaResearch Fellow, Military Institute of Medicine in WarsawVerified email at wim.mil.pl
Mohammed I. KhanPostdoctoral Scholar, Department of Otolaryngology-Head & Neck Surgery (OHNS), Stanford UniversityVerified email at stanford.edu
Pawel Golikprofessor, University of WarsawVerified email at igib.uw.edu.pl
Camillo PortaTranslational Oncology, IRCCS Istituti Clinici Scientifici MaugeriVerified email at icsmaugeri.it
Jacek MackiewiczUniwersytet Medyczny w PoznaniuVerified email at ump.edu.pl
Lukasz SzymanskiInstitute of Genetics and Animal Biotechnology, Polish Academy of SciencesVerified email at igbzpan.pl
Sławomir Lewicki, PhDInstitute of Genetics and Animal Biotechnology, Polish Academy of SciencesVerified email at igbzpan.pl
John A. PetrosProfessor of Urology, Emory UniversityVerified email at emory.edu
Fabio BucchieriFull Professor in Human Anatomy, University of PalermoVerified email at unipa.it
Jerzy S. CzarneckiSenior Lecturer, Łódź University, PolandVerified email at uni.lodz.pl
Valentina Di FeliceUniversità degli studi di PalermoVerified email at community.unipa.it
Jan LubinskiPomeranian Medical Univeristy in SzczecinVerified email at pum.edu.pl
Krzysztof BoguszMedical University of WarsawVerified email at student.wum.edu.pl
Magdalena KowalewskaCentrum Onkologii-InstytutVerified email at coi.pl
Krzysztof J. FilipiakUM MCS Warsaw, Uczelnia Medyczna im. Marii Skłodowskiej-Curie w WarszawieVerified email at uczelniamedyczna.com.pl

Anna M. Czarnecka

Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.

Verified email at coi.pl - Homepage

melanoma cancer stem cells immunotherapy sarcoma renal cell cancer


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Choosing the right cell line for renal cell cancer research KK Brodaczewska, C Szczylik, M Fiedorowicz, C Porta, AM Czarnecka Molecular Cancer 15 (1), 83, 2016	265	2016
Molecular Biology of Osteosarcoma AM Czarnecka, K Synoradzki, W Firlej, E Bartnik, P Sobczuk, ... Cancers 12 (8), 2130, 2020	252	2020
Mitochondrial chaperones in cancer: from molecular biology to clinical diagnostics AM Czarnecka, C Campanella, G Zummo, F Cappello Cancer biology & therapy 5 (7), 714-720, 2006	187	2006
Targeted Therapy in Melanoma and Mechanisms of Resistance AM Czarnecka, E Bartnik, M Fiedorowicz, P Rutkowski International Journal of Molecular Sciences 21 (13), 4576, 2020	137	2020
The role of the cell–cell interactions in cancer progression K Kamińska, C Szczylik, ZF Bielecka, E Bartnik, C Porta, F Lian, ... Journal of cellular and molecular medicine 19 (2), 283-296, 2015	132	2015
Three‐dimensional cell culture model utilization in cancer stem cell research ZF Bielecka, K Maliszewska‐Olejniczak, IJ Safir, C Szczylik, ... Biological Reviews 92 (3), 1505-1520, 2017	130	2017
Mitochondrial DNA mutations in human neoplasia AM Czarnecka, P Golik, E Bartnik Journal of applied genetics 47 (1), 67-78, 2006	129	2006
Mitochondrial NADH-dehydrogenase subunit 3 (ND3) polymorphism (A10398G) and sporadic breast cancer in Poland AM Czarnecka, T Krawczyk, M Zdrożny, J Lubiński, RS Arnold, W Kukwa, ... Breast cancer research and treatment 121 (2), 511-518, 2010	114	2010
Resistance to tyrosine kinase inhibitors in clear cell renal cell carcinoma: From the patient's bed to molecular mechanisms M Buczek, B Escudier, E Bartnik, C Szczylik, A Czarnecka Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1845 (1), 31-41, 2014	113	2014
Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first‐line treatment for advanced leiomyosarcoma: A propensity score matching analysis from … L D’Ambrosio, N Touati, JY Blay, G Grignani, R Flippot, AM Czarnecka, ... Cancer 126 (11), 2637-2647, 2020	103	2020
The Role of Hypoxia and Cancer Stem Cells in Renal Cell Carcinoma Pathogenesis A Myszczyszyn, AM Czarnecka, D Matak, L Szymanski, F Lian, ... Stem Cell Reviews and Reports 11 (6), 919-943, 2015	90	2015
Rhabdomyosarcoma of the head and neck in children J Radzikowska, W Kukwa, A Kukwa, A Czarnecka, A Krzeski Contemporary Oncology 19 (2), 98-107, 2015	82	2015
Mechanisms of acquired resistance to tyrosine kinase inhibitors in clear-cell renal cell carcinoma (ccRCC) Z F Bielecka, A M Czarnecka, W Solarek, A Kornakiewicz, C Szczylik Current signal transduction therapy 8 (3), 219-228, 2013	81	2013
Vitamin D receptor gene polymorphisms in breast and renal cancer: Current state and future approaches (Review) MI Khan, ZF Bielecka, MZ Najm, E Bartnik, JS Czarnecki, AM Czarnecka, ... International journal of oncology 44 (2), 349-363, 2014	78	2014
Heat shock protein 10 and signal transduction: a “capsula eburnea” of carcinogenesis? AM Czarnecka, C Campanella, G Zummo, F Cappello Cell stress & chaperones 11 (4), 287, 2006	78	2006
Current approaches in identification and isolation of human renal cell carcinoma cancer stem cells MI Khan, AM Czarnecka, I Helbrecht, E Bartnik, F Lian, C Szczylik Stem Cell Research & Therapy 6 (1), 178, 2015	77	2015
Upon oxidative stress, the antiapoptotic Hsp60/procaspase-3 complex persists in mucoepidermoid carcinoma cells C Campanella, F Bucchieri, NM Ardizzone, A Marino Gammazza, ... European Journal of Histochemistry 52 (4), 221-228, 2009	72	2009
Insulin-like growth factor-1 signaling in renal cell carcinoma AF Tracz, C Szczylik, C Porta, AM Czarnecka BMC cancer 16 (1), 453, 2016	63	2016
The therapeutic aspects of the endocannabinoid system (ECS) for cancer and their development: from nature to laboratory. MI Khan, AA Sobocińska, AM Czarnecka, M Król, B Botta, C Szczylik Current pharmaceutical design, 2015	63	2015
Insulin and IGFs in renal cancer risk and progression W Solarek, AM Czarnecka, B Escudier, ZF Bielecka, F Lian, C Szczylik Endocrine-related cancer 22 (5), R253-R264, 2015	61	2015

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors